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Foreword
It has been a privilege and a pleasure to have been associated with CSG Centre of Society and 
the Life Sciences since its inception in 2002/03. Under Hub Zwart’s inspirational and inclusive 
leadership, CSG has become an internationally recognised beacon for the development of 
the society in science and the science in society agendas. Over the last decade, its notable 
achievements include the building of a network of participating universities in the Netherlands; 
the fostering of interdisciplinary collaborations; joint activities with other Centres of Excellence 
in Europe and North America; academic conferences, seminars and workshops; the provision 
of opportunities for PhD students and post-docs, and most significantly a variety of innovations 
in public outreach and public engagement. The Centre leaves a splendid and solid legacy; its 
activities will be sustained and further developed in the pursuit of responsible research and 
innovation.
George Gaskell
Chairman of CSG’s International Scientific Advisory Board 
Pro-director, London School of Economics, UK
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The Centre for Society and Genomics (CSG) was established in 2004, funded by NGI (the 
Netherlands Genomics Initiative). Funding was continued in 2008. This report summarises the basic 
outcomes of almost a decade of interactive societal research, in close collaboration with the other 
centres of the NGI network.
There are two reasons for presenting these results. First of all, at the end of this year, the CSG 
Next programme (2008-2013), encompassing more than 50 research projects conducted at 10 
Dutch universities, will be completed. Moreover, we are currently preparing ourselves for the 
years to come. The network of principal investigators, together with the research communities 
they represent and the societal and international networks they are involved in, have agreed to 
continue to work together, on the basis of mutual learning, transdisciplinary collaboration and 
collegial support. Notably, we offer our networks, experiences and expertise to help prepare the 
ground for promoting Responsible Research and Innovation (RRI) in the context of Horizon2020, 
together with our European colleagues.
This report summarises what our type of research can achieve and how we want to continue our 
activities in the future. After a concise sketch of the life sciences landscape as it has evolved 
during the past seven decades or so, we explain how CSG came about and what kind of approach 
we have developed. Subsequently, we list our main results, notably in the form of project vignettes, 
so as to make the harvest of the CSG Next programme as tangible and concrete as possible. Finally, 
we explain how we see our role in the future.
As is already indicated by the title: this is not merely a retrospective summary of our results 
(CSG harvest), but an invitation to readers (from academia, industry, policy and civil society) to 
reassemble and to optimally prepare ourselves for things to come, by strengthening and broadening 
our collaborative efforts, building on what we have achieved so far.  
Summary
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Prelude: 
from molecular life sciences to 
genomics and post-genomics - 
a short history of a scientific 
revolution
During the past 70 years, life science research 
has changed dramatically in terms of pace 
and scale, but also in terms of methods, 
technologies and research funding schemes. In 
1943, Nobel laureate Erwin Schrödinger argued 
that life should be studied at the molecular 
level and that physicists and biologists should 
learn to work together. Ten years later, 
Watson (a biologist) and Crick (a physicist) 
unravelled the molecular structure of DNA, 
building on data produced by crystallographers 
Rosalind Franklin and Maurice Wilkins. The 
spread of the ‘molecularization’ of life from 
laboratory to society surfaced in the form of 
the biotechnology revolution, unleashed by 
genetic engineering techniques developed 
by Boyer and Cohen in 1973, and amplified 
by subsequent innovations such as the PCR-
technique developed in 1983 by Kary Mullis 
(working for a Bay Area biotech company 
called CETUS Corporation). Subsequently, 
the shift from single-gene to genome-oriented 
(genomics) approaches paved the way for 
the Human Genome Project (HGP), building 
on high throughput, automated sequencing 
technologies. In 1993, with the appointment 
of Francis Collins, the HGP really got off the 
ground and ten years later (three years after 
the famous press conference in 2000) the first 
finished sequenced of a (composite) human 
genome was finally published. Currently, the 
revolution has begun to propagate to other, 
‘post-genomics’ arenas such as personalised 
medicine, synthetic biology, systems biology, 
proteomics, and a whole variety of other forms 
of –omics research. On the societal level, 
important new debates and developments 
include the personalised ($ 1000) genome, 
neuro-enhancement and the macro-societal 
turn towards a more sustainable, bio-based 
(post-fossil fuel) society, also known as the 
‘second’ (i.e. bio-based) industrial revolution. 
These developments offer challenging prospects 
for sustainability, employment and health, but 
also entail possible conflicts and even global 
collisions between potential ‘winners’ and 
‘losers’. Important issues such as naturalness 
vs. refurbishing nature, self-determination 
vs. surveillance and control, global justice vs. 
exploitation, and credibility vs. uncertainty 
and lack of trust are involved. In other words, 
the techno-scientific and societal, ethical and 
socio-economic dimensions of these complex 
transitions are closely intertwined from the 
very outset. They must be addressed in an 
interdisciplinary, interactive way, through 
research, public deliberation and mutual 
learning.
1943 Erwin Schrödinger, What is life?
1953  Discovery of the structure of DNA, 
Watson and Crick
1973  Genetic engineering / 
Biotechnology, Cohen and Boyer
1983  Invention of the Polymerase Chain 
Reaction, Kary Mullis
1993  Francis Collins appointed as Director 
of the Human Genome Project at NIH
2003  Publication of the finished human 
genome sequence
2013  Personalised medicine, synthetic 
biology and the bio-based economy
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From the 1970s onwards, sensitivity to the 
societal implications of the techno-scientific 
developments outlined above quickly increased. 
In 1974 for instance, a committee of prominent 
scientists lead by Nobel laureate Paul Berg 
published a paper on the potential biohazards 
of recombinant DNA molecules in Science 
and in 1975, a sizable group of prominent life 
scientists convened in Asilomar (California) 
for a conference to address these issues. They 
even discussed the option of a moratorium on 
potentially hazardous experiments. The par-
ticipants felt that anticipatory deliberations on 
the possible societal implications of emerging 
life sciences should become an intrinsic part of 
responsible research. Thus, the Asilomar Con-
ference became an important marker in the his-
tory of deliberations on life sciences and society.
In 1988, when the preparations for the Human 
Genome Project (HGP) were in full swing and 
HUGO (the international Human Genome Or-
ganisation) had its first meeting at Cold Spring 
Harbor, this issue resurged. At the press confer-
ence announcing his appointment as first Direc-
tor of the HGP, James Watson announced that 
3 % (later: 5 %) of the NIH budget for genom-
ics should be spent on research concerning the 
ethical, legal and social implications (ELSI) of 
sequencing the human genome. This idea be-
came a model worldwide (Table 1, next page). In 
various countries, genomics research was now 
flanked by societal programmes addressing the 
ethical, legal and socials implications (ELSI) or 
aspects (ELSA) of genomics. In other words, 
1975 Asilomar Conference
1988 Announcement of ELSI 
1990 Launch of ELSI programme
1994 Birth of ELSA label (FP4)
2004 Launch of CSG
2008 Launch of CSG Next
2013 Completion of CSG Next
 Launch of RRI concept
  Network for Society and the Life 
Science
“Who would nowadays dream, 
even for an instant, of stopping the 
movement, the discourse of science 
in the name of anything whatsoever 
that might result from it? Things 
have already happened, they show 
where we are going, from molecular 
structures to atomic fission. Who 
can think, for even an instant, that 
the revelation of this new power 
can be stopped? That it is still 
possible not to obey the command 
of contemporary science – Go on! 
Continue! 
Keep producing more knowledge!” 
Jacques Lacan 1991, p. 120)
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a close liaison evolved between HUGO and 
ELSA.
Like the HGP itself, the US ELSI programme 
was formally established in 1990. Its mission 
was to anticipate and address the ethical, legal, 
and social implications of genetic and genomic 
research. From 3 up to 5% of NHGRI research 
budget would be devoted to this type of work. 
Thus, NIH became the largest public funder of 
bioethics research in the world. Triggered by 
the American example, other countries began 
to set up similar ELSI / ELSA genomics pro-
grammes of their own. In the United Kingdom, 
this led to a network of ELSA centres funded 
by the Economic and Social Research Council (the 
ESRC Genomics Network: EGN). 
In the Netherlands, during that same period, 
the Netherlands Genomics Initiative (NGI) was 
established in 2002. For more than a decade, 
this funding agency invested 560 million euros 
in genomics research, conducted at 15 genom-
ics centres. 5 % of its budget was spent on 
ELSA activities, on the one hand in the form of 
an NWO programme issuing calls for research-
er-driven, stand-alone projects (entitled: “The 
societal component of genomics research”) and, 
on the other hand, in the form of a Centre for 
Society and Genomics (CSG), established in 
2004. Subsequently, building on the results of 
CSG I (2004-2008), the CSG Next programme 
was launched in 2008 as an effort to combine 
these various strands of Dutch ELSA activities. 
Since 2004, CSG has conducted more than 
70 research projects and a plethora of societal 
activities. Proximity (i.e. collaboration with the 
other centres of the genomics network) and in-
teraction (i.e. the combination of ELSA research 
with education, communication, valorisation 
and societal outreach) have been key elements 
of our work. In this document we will outline 
why this type of research is important and what 
we have achieved.    
Country Acronym Programme Funding agency Year
USA ELSI Ethical, Legal and Social Implications NIH / NHGRI 1990
Canada GE3LS Genomics-related Ethical, Environmental, 
Economic, Legal and Social Aspects
Genome Canada 2000
South-Korea ELSI Ethical, Legal and Social Implications Government of 
South-Korea
2001
United Kingdom EGN ESRC Genomics Network (Cesagen, 
Innogen, Egenis, Genomics Forum)
ESRC 2002
Netherlands CSG, 
MCG
Centre for Society and Genomics (now: 
Life Sciences); Societal Component of 
Genomics Research
Netherlands 
Genomics Initiative
2002
Norway ELSA ELSA Programme Research Council of 
Norway
2002
Germany, 
Austria, Finland
ELSAGEN Transnational Research Programme GEN-AU, FFG, DFG, 
Academy of Finland
2008
Table 1: Overview of ELSI/ELSA Programmes
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In December 2002, the Netherlands Genomics 
Initiative (NGI) decided to establish a Centre 
for Society and Genomics (CSG) at the Faculty 
of Science, Radboud University Nijmegen, 
led by Prof. Hub Zwart, following a call that 
invited experts in the field of ELSA research for 
setting up such a centre.  
To those involved in setting up CSG at the 
time it was clear that they were taking part in 
an experiment and involved in developing a 
novel kind of organisation, without precedent 
in the Netherlands. CSG became a national 
centre, responsible for developing and 
conducting a national programme of research, 
combining mass and focus. Until then, this 
type of research had been implemented 
through stand-alone projects and open calls. 
As a national network did not yet exist, it was 
built through research. All major players were 
assembled into one programme.
CSG adhered to the ELSA profile. Research 
was conducted in close interaction with 
education, communication and societal 
outreach. Rather than opting for a particular 
identity in terms of discipline (such as 
Bioethics, STS or TA), the objective was to 
join forces and to combine tools, insights and 
experiences from a broad range of relevant 
fields. Moreover, CSG was part of the network 
of	the	centres	of	excellence	of	NGI.	Virtually	
all research projects of the CSG programme 
entailed collaborations or at least interactions 
with genomics research centres at various stages 
of the research trajectory.
CSG’s mission was to analyse, assess and 
improve the conditions for societal embedding 
of genomics. CSG developed a portfolio of 
20 research projects, which were conducted 
at various universities throughout the 
Netherlands, in combination with education 
and communication activities, such as the 
public website All about DNA. In 2007, when 
a sequel programme for genomics research in 
the Netherlands was launched, NGI decided, 
on the basis of a mid-term review in 2006 and 
other assessments, that CSG should continue 
and that all ELSA-type activities should be 
brought together into one comprehensive 
programme, combining mass, focus and 
visibility. CSG was to combine and coordinate 
all research, communication and education 
activities that were previously the responsibility 
of several organizations (NGI, the Genomics 
Centre for Society and Genomics 
(CSG)
“The money dedicated to [ELSA] 
does more than simply finance 
research, dialogue and education; 
it also helps to erect buildings of 
knowledge and practice: social 
institutions of intermediary 
character that are geographically 
and organisationally close to the 
research centres with which they 
interact. These institutions serve 
as public and academic forums for 
converging sciences and societal 
actors.”  (Stegmaier 2009)
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Centres and the NWO programme MCG).
CSG Next was launched on 1 January 2008. 
The new programme was a joint endeavour of 
all the centres of the NGI network (sixteen 
partners in total), under the lead of CSG, and 
it entailed collaborations with partners from 
society and industry as well. The Business Plan 
2008-2012 stated basically the same mission 
as before: to analyse (through conceptual and 
empirical research), assess (in a critical manner) 
and improve (through recommendations 
and interventions) the prospects for societal 
embedding of genomics, by aligning research 
and policy agendas and feeding (and improving 
the quality of) societal and policy-debates over 
genomics-related issues. 
This mission was translated into four main 
objectives:
•	 	add	to	the	academic	body	of	knowledge	
about society-genomics relations
•	 	improve	quality	of	public	debate	on	
genomics
•	 strengthen	the	governance	of	genomics
•	 	educate	researchers,	professionals	and	
citizens to assess genomics and its value for 
society.
The new plan was not only supported by all 
NGI centres, but also positively assessed by 
international peers. 
CSG Next integrated communication with 
societal interaction, so that communication 
and interaction provided input for research 
activities and vice versa. The proximity of 
ELSA research to the genomics research 
infrastructure allowed for the study of on-going 
and emergent developments in genomics. Thus, 
CSG’s research could anticipate and affect the 
actual course that science and its applications 
were taking. 
“The Review Committee was 
impressed with the results achieved 
by CSG. CSG has put societal 
aspects on the research agenda 
in an integrated manner and 
has pursued a transdisciplinary 
approach by bringing together 
researchers from different 
disciplines. This collaboration 
has not grown spontaneously: 
it took time, critical mass and 
engagement. An important success 
factor is that CSG researchers work 
closely together with genomics 
researchers, not only by regular 
meetings, but also by having a desk 
in or close to laboratories where 
genomics researchers work. CSG 
has shown to be successful. The 
CSG approach is a very strong 
concept and a best practice for 
other research programmes and 
organisations.”
(Breimer et al, Mid-Term Review Committee 
NGI, 2011)
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Thus, CSG Next developed into a large-
scale centre for interactive research and 
communication, with approximately 50 
research projects designed and conducted in 
collaboration with the other 15 centres of 
the NGI genomics network. CSG research 
provided challenging opportunities for other 
reasons as well. It has been a test-bed for a new 
style of doing and organizing research. As a 
national research centre, CSG developed an 
open network of trans-university collaborations 
for developing and conducting its interactive 
research programme. Proximity to (and 
collaboration with) prominent large-scale life 
sciences programmes was a key feature of the 
programme. 
In 2011, CSG was subjected to a formal 
external review. The review committee judged 
the CSG approach as a very strong concept and 
a best practice for other research programmes.  
Over the years, the focus of research broadened 
from ‘genomics’ to ‘life sciences’. In 2011, this 
was reflected in CSG’s new name: CSG Centre 
for Society and the Life Sciences. 
Participants of csg’s 
international scientific 
conference 
Amsterdam, May 2010
2
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Scientific Advisory Board of CSG Next (2013)
Prof George Gaskel London School of Economics, UK (chair)
Dr Roger Busch (formerly) Ethik-Institut Technik-Theologie-
Naturwissenschaften, München, Germany
Prof Anne Cambon-Thomsen INSERM Toulouse, France
Prof Ruth Chadwick CESAGen, Cardiff, UK
Prof Herbert Gottweis Department of Political Sciences, Universität Wien, Austria
The 50 projects of the CSG Next programme, developed by principal investigators and other 
project managers, were subjected to a quality assessment by the Scientific Advisory Board of CSG.
Programme Committee of CSG Next (2013)
Hub Zwart Philosophy of Science ISIS, Radboud University 
Nijmegen
Scientific Director
Jacqueline Broerse Science and Technology 
Studies
Athena Institute, VU University 
Amsterdam
Principal Investigator
Martina Cornel Community Genetics VU University Medical Center, 
Amsterdam
Principal Investigator
Michiel Korthals Applied Philosophy CITE, Wageningen University Principal Investigator
Patricia Osseweijer Science Communication Biotechnology and Society, Delft 
University of Technology
Principal Investigator
Arend-Jan Waarlo Science Education Freudenthal Institute, Utrecht 
University
Principal Investigator
Guido de Wert Bioethics HES, Maastricht University Principal Investigator
Management Team of CSG Next (2013)
Hub Zwart Scientific Director
Gijs van der Starre Managing Director
Frans van Dam Communication Manager
Maud Radstake Project Manager
Maria-Lucia Cantore Office Manager
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3
In order to realise our mission to analyse, 
assess and improve the societal embedding of 
genomics, our research not only involved a 
combination of empirical analyses and critical 
assessments, but also resulted in options for 
improvement or concrete recommendations 
and activities, in order to further societal embed 
and to stimulate interaction between society 
and genomics. Another basic characteristic 
of CSG research has been that interactions 
with genomics researchers, professionals, 
societal organisations and other stakeholders 
are not limited to the development and / or 
dissemination stages of our research, but rather 
constitutes an integrated dimension of our 
methodology, our work. In a number of 
publications, statements and meetings, these 
ideas have been further developed.
One CSG project was explicitly devoted to 
the question “What is ELSA genomics?” In 
September 2008 a workshop was organised 
involving several ELSA researchers from the 
Netherlands and abroad, resulting in a special 
issue of EMBO reports (Science and Society 
series on convergence research, Stegmaier 
2009). In one of these reports, a general profile 
of ELSA genomics research is outlined (Zwart 
& Nelis 2009). At least four important features 
are typical for ELSA genomics research, 
namely: proximity (critical participation 
and embedding in genomics programmes), 
early anticipation (of social issues involved in 
genomics research), interactivity (encouraging 
stakeholders and publics to assume an active 
role in ELSA research), and interdisciplinarity 
(bridging boundaries between research 
communities such as bioethics, philosophy 
and STS). In a similar document written on 
behalf of NGI and entitled The Societal Aspects 
of the Life Sciences 2020 it is concluded that 
ELSA research consists of four basic activities: 
(a) identification of (ethical, legal and social) 
issues; (b) interpretation and analysis of these 
issues; (c) organised interaction and dialogue 
with stakeholders (including publics) and (d) 
interaction with policy, politics and professional 
practices (Bijker et al 2011). 
Recently, both on the European and on 
the national level, a new concept has 
been launched: Responsible Research and 
Innovation. In the opening lines of A vision of 
Responsible Research and Innovation (2013) René 
von Schomberg argues that “RRI has become 
an increasingly important phrase within policy 
narratives, in particular in Europe, where it will 
Characteristics of ELSA research
•	 Proximity to life science research
•	 	An	anticipatory, forward-looking 
approach; a focus on the agenda-
setting and design stages of 
innovation trajectories, rather than on 
the product stage
•	 	Interaction with a broad range of 
societal stakeholders (media, policy, 
NGO, industry) as integral part of the 
research
•	 	Interdisciplinarity: ELSA research as 
a converging field involving a broad 
range of disciplines (philosophy of 
science, bioethics, social science, 
TA, STS, innovation studies, science 
communication etc.)
•	 	A	focus	on	micro-analysis (‘case 
studies’) rather than on macro 
analysis (socio-economic studies)
•	 	Drawing	on	a	wide variety of sources: 
from academic philosophy via policy 
reports up to media coverage of 
public debates and genres of the 
imagination (genomics novels, 
genomics movies and the like) 
The CSG Approach:  
From ELSA to RRI 
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be a cross-cutting issue under the prospective 
EU Framework Programme for Research and 
Innovation Horizon 2020”. And yet, “there 
is no agreed definition of the concept, and 
approaches how it should be implemented 
may vary”. Indeed, the field is explicitly 
invited to join the debate as to what RRI 
exactly is. In two recent publications on RRI 
(Von	Schomberg	2011,	2013),	the	following	
definition is proposed: Responsible Research and 
Innovation is a transparent, interactive process 
by which societal actors and innovators become 
mutually responsive to each other with a view 
to the (ethical) acceptability, sustainability and 
societal desirability of the innovation process and 
its marketable products (in order to allow a proper 
embedding of scientific and technological advances 
in our society).
Another	recent	report	(Van	den	Hoven et al.) 
defines RRI as follows. It is: 
•	  Anticipatory: Anticipation asks researchers 
and innovators to include new perspectives 
in the research and innovation process and 
to think through various possibilities to be 
able to design socially robust agendas for risk 
research and risk management.
•	  Inclusive: Inclusiveness asks researchers and 
innovators to involve diverse stakeholders 
(such as users and NGOs) in the process 
to broaden and diversify the sources of 
expertise and perspectives.
•	  Reflexive: Reflexivity asks researchers 
and innovators to think about their own 
ethical, political or social assumptions to 
enable them to consider their own roles and 
responsibilities in research and innovation 
as well as in public dialogue. Reflexivity 
should raise awareness for the importance of 
framing issues, problems and the suggested 
solutions.
•	  Responsive: If research and innovation 
claim to be responsible, it has the capacity 
to change its direction or shape when 
it becomes apparent that the current 
developments do not match societal 
needs or are ethically contested. Hence, 
responsiveness refers to the flexibility and 
capacity to change research and innovation 
processes according to public values. (p. 58)
From this definition it is clear that there is 
continuity between the ELSA and the RRI 
approach and that responsible research can 
build on the ELSA legacy of the past two 
decades (1994-present). Still, there is a new 
emphasis in RRI in comparison with ELSA, 
namely the focus on socio-economic benefits 
and collaboration with private and industrial 
partners, the use of ethics as a design principle 
for technology (for example: privacy through 
design) as well as the ensuring of market 
accountability through standards, certification, 
accreditation and labels as a new form of 
governance to manage the floods of products 
coming	to	the	market.	Von	Schomberg	(2013)		
notably refers to “…the ambition of the 
European Union to ensure that research and 
innovative ideas can be turned into products 
“There can be no viable innovation 
in the life sciences without a proper 
‘landing’ in society, as science and 
technology only function when 
they are socially well embedded. 
For an adequate embedding of 
innovations in society, research 
into the societal aspects of 
specific scientific and technical 
developments will continue to be 
necessary, now and in the future.”
(Bijker et al, The Societal Aspects of the Life 
Sciences 2020)
3
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3
and services that create jobs and prosperity, 
as well as help preserve the environment and 
meet the societal needs of Europe and the 
world” (p. 11). The point of RRI is to help 
achieve this ambition:  “RRI has the potential 
to make research and innovation investments 
more efficient, while at the same time focusing 
on global societal challenges” (p. 16). Inclusion 
of ethics beforehand, it seems, will lead to less 
contestation of innovations afterwards.
Involving societal input in science and 
technology innovation implies that ELSA 
/ RRI- researchers become part of the very 
processes they study, immersing themselves in 
research consortia whose work they intend to 
critically assess. The tension between ‘going 
native’ and giving voice to critical concerns 
is there to stay. For the ELSA community, 
the new liaison (or even ‘marriage’ with) RRI 
and its socio-economic agenda (including the 
commodification of research this seems to 
entail) raises an issue that is not unlike the one 
that haunted Elsa of Brabant, the female lead 
in Wagner’s Lohengrin: will there be questions 
we are no longer supposed to (but will find 
impossible not to) ask?
Discussing the 
flu pandemic
LUX-Nijmegen, September 2009
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4
“Scientists aren’t generally prone to 
effusiveness. We are privately excited about 
our work, but in public we often, and 
rightly, emphasize skepticism and caution. 
But there are exceptional moments where 
skepticism is set aside, electricity fills the 
room, and a scientist with palpable passion 
and flashing eyes describes unabashedly 
a change in the landscape that will have 
lasting significance. Just a few months into 
the new millennium, I had that experience 
… After much anticipation, and many 
tumultuous moments, the achievement of 
an almost impossible audacious goal that 
had motivated all of us for a decade was 
now essentially assured. (p.1)”
This is how Francis Collins (2010) described 
the atmosphere shortly before the presentation 
of the human genome sequence in the 
year 2000. It was a moment of big hopes 
and stellar expectations. Yet, since then, 
the immediate implications of the human 
sequence for medicine and health have been 
‘underwhelming’, to put it mildly. Hardly any 
drugs or therapies resulted from this costly, 
‘big science’ investment. It soon became 
clear, not only that life as such is staggeringly 
complex from a biological point of view, but 
also that the translation and implementation 
of new forms of knowledge and information 
into medical practice and daily life is beset by 
complexities as well. In other words, not only 
biological life, also societal life is complex. It 
is only now, during the present decade, that 
practical options and benefits become gradually 
visible, but even now, in many cases, these 
benefits often entail mixed blessings. The 
implementation of genomics in health care 
is not a matter of technological dexterity and 
sizable data sets only. It is also (perhaps even 
more so) a question of policies, regulations, 
culture, world-views and a whole range of other 
socio-cultural facets. In other words, in order to 
turn knowledge into practice, genomics experts 
and ELSA experts, but also policy-makers, 
professionals, patients and teachers will have to 
continue to learn to work together. 
 This not only goes for the health domain, 
but also for agricultural, industrial and 
environmental genomics. Not only genomics 
insights (and the biological systems studied 
by genomics) are complex, the societal fabrics 
and tissues in which this knowledge must 
become embedded are staggeringly complex 
as well. And indeed, to put it in mathematical 
terms, ‘complex’ times ‘complex’ is squared 
complexity. This means that the focus of our 
projects often is on case studies: punctuated 
samples allowing us to probe a bewilderingly 
complex global reality. But very often, these 
ELSA vignettes entail important lessons of 
much wider relevance. It is in this manner that 
the prospects opened up by genomics, such 
as personalised medicine and the bio-based 
society, can be realised, not by way of one 
big gesture, and not in a top-down fashion, 
but through continuous effort. Therefore, the 
projects results, which are listed below in the 
form of an anthology of project vignettes, must 
be seen as preliminary harvest of a common 
research effort that must and will continue 
during the years to come. 
Expectations and deceptions: 
the issue of complexity
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In general terms, our main results can be 
summarised as follows:
•	 	Although	genomics	(i.e.	sequencing	
and understanding genomes) as such is 
a basic and generic field, when it comes 
to implementation and application it is 
not a matter of ‘one size fits all’. Rather, 
implementation has to be carefully 
tailored to specific circumstances, in 
close interaction with the various ‘local’ 
stakeholders involved. This involves mutual 
learning (‘implementation work’).
•	 	In	many	fields	of	application,	a	basic	
decision has to be made: do we opt for 
self-determination or standardisation and 
surveillance, for an open-source or rather 
for a proprietary course, for a nature-friendly 
or an exploitative attitude? In other words, 
the real meaning of genomics for human life 
and society will be determined in the socio-
cultural arena, not by the technology as 
such.
•	 	In	order	to	use	new	knowledge	forms	(such	
as genomics) for addressing the major 
global societal challenges of today, research 
disciplines (in science, the social sciences 
and the humanities) must continue to learn 
to work together and opt for a collaborative 
rather than an introvert, self-centered 
approach.   
•	 	The	genomics	(or	life	sciences)	revolution	
is a dynamic, time-consuming, cascading 
process, rather than a dramatic, punctuated 
event (such as the sequencing of the human 
genome).
•	 	So	far,	the	biggest	impact	of	genomics	has	
been a cultural one: rather than leading to 
new products or therapies, it has profoundly 
changed our view of life, nature and 
ourselves.
This general message has been implemented 
and brought to life in various concrete settings 
by CSG research projects. 
Statue of Marjolein 
Kriek, the first woman 
whose genome has been 
sequenced
5Results
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Anthology of project vignettes1  
Health
“The amount and detail of 
information offered by new 
screening techniques such as 
whole genome sequencing 
does not automatically deep-
en our understanding of the 
prospects of embryos. From 
an ethical point of view, the 
increasing complexity will 
rather lead to challenges to 
reproductive autonomy and 
the right of the child to an 
open future, and may com-
plicate the responsibility of 
clinicians regarding the wel-
fare of the future child.” 
Kristien Hens, Guido de 
Wert: Towards the Transpar-
ent Embryo?
“Attempts at resolving ten-
sions pertaining to the gov-
ernance of biobanks often 
reproduce these very same 
tensions in other ways. This 
is the main irony of ‘Biobank 
Governance’: problems re-
lated to a lack of governance 
easily evolve into problems 
related to an overkill of gov-
ernance.” 
Martin Boeckhout, Gerard de 
Vries: ELSA Involvement in 
Biobank Governance
“Our outcomes reflect a 
turning phase in genomics. 
After hopes and promises 
about the potential con-
tribution of genomics for 
prediction and prevention 
of common disorders began 
to fade, attention shifted 
to monogenic subsets of 
common complex disor-
ders. Here, there are several 
potential applications that 
might be implemented in 
health care. For instance, 
for some cardiac disorders, 
diabetes and cancers, tests 
have been developed that 
can detect high-risk genes, 
notably for index patients 
who are not detected in pri-
mary care.” 
Eric Vermeulen, Martina 
Cornel: Governance of pre-
ventive genomics
“The newness of biobank-
ing not only resides in the 
collection and storage of 
biomaterials and data for 
future and unspecified re-
search, but also in patients 
and citizens acquiring new 
forms of agency and devel-
oping new roles in the bio-
medical research system.”
 
Conor Douglas, Carla van El: 
A wealth of data
“Early identification, pre-
vention and treatment of 
antisocial behavior raise 
concerns about labeling and 
stigmatization. Yet, the juve-
nile participants in our pro-
ject did not react in this way. 
Rather, they emphasized the 
possibility of making their 
own choice, which allows 
them to take responsibility.” 
Dorothee Horstkötter, Guido 
de Wert: The promise and 
pitfalls of the genomics of 
antisocial behaviour
Het is soms om gek van te worden… Want hoe zit het nou precies met genen en 
psyche? Is het echt waar dat bepaalde psychische aandoeningen erfelijk zijn? 
En dat er genen zijn waarop we kunnen ingrijpen en daarmee ervoor zorgen dat 
mensen niet meer ‘ziek’ of ‘gek’ worden? Wat betekent genenonderzoek voor  
de omgang met psychische aandoeningen? En wat betekent het voor de beeld-
vorming van deze ziekten?  
Uit gesprekken met mensen die zelf een psychische aandoening hebben of 
mensen die daarmee in aanraking komen als familie maar ook vanuit hun  
beroep, blijkt dat er nog veel onduidelijk is als het gaat over psyche en genen. 
Niet gek dus dat hierover veel vragen zijn. 
In dit boek kunt u lezen wat er tot dusver bekend is over de samenhang tussen 
genen en psychische aandoeningen en wat nieuwe inzichten betekenen voor 
patiënten of familieleden. Het blijkt allemaal complexer dan gedacht. Verwacht 
dus geen kant-en-klare antwoorden, maar wél een goed beeld van alles wat r 
op dit moment speelt. 
Om gek van te worden… 
Het complexe verband tussen psyche en genen
Veronique Huijbregts 
samen met Ingrid Baart
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1.      Names refer to principal researcher and project manager respectively, although in many projects, more 
researchers and/or supervisors were involved. For more info please consult: www.society-lifesciences.nl
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“Dear Minister of Health, 
Welfare and Sport. Searching 
the entire genome for ge-
netic causes will often allow 
a diagnosis to be made, but 
the advantages of analys-
ing an individual’s ‘personal 
genome’ without medical 
indication depend on the 
realisation of the ideal of 
personalised forms of pre-
vention and treatment (‘per-
sonalised medicine’). This 
remains largely something 
for the future.” 
Wybo Dondorp, Guido de 
Wert: The 1000 dollar ge-
nome 
“Although the development 
of alternatives to animal 
models was generally re-
garded as a perfect solution 
for addressing the issue of 
animal experimentation, 
funding strategies tended 
to shift the focus from value 
conflicts to technical solu-
tions and depolarisation. 
This implied a broadening of 
the concept of ‘alternatives’ 
so that, in the end, no sig-
nificant reduction of animal 
experiments was achieved. 
A real reduction presupposes 
that value conflicts are ex-
plicitly addressed rather than 
evaded.” 
Meggie Pijnappel, Hub 
Zwart: Developing animal 
testing alternatives: social 
values in dispute
“The discussion in the 
Netherlands on neonatal 
screening so far has focused 
primarily on equality in 
health care and concerns 
over stigmatisation of cer-
tain groups in society. Our 
results support midwives, 
obstetricians and GPs in pro-
viding tailored health care 
for pregnant women from 
various ethnic backgrounds, 
focussing on anaemia and 
HbP (carrier) status in differ-
ent ethnic groups.”
Suze Jans, Martina Cornel: 
Neonatal Screening and 
beyond: Integration of he-
reditary hemoglobinopathy 
screening into primary care
“New techniques for de-
tecting foetal abnormalities 
find their way into prenatal 
screening strategies, causing 
the scope of testing to be 
far from evident. The deci-
sion what to test for is open 
for discussion. We conclude 
that replacement of one 
standard test by the alterna-
tive of an “individualised 
choice” better accords with 
the basic aim of prenatal 
screening.” 
Antina de Jong, Guido de 
Wert: Individualized choice 
in prenatal screening
“General practitioners 
should directly ask patients 
suffering from diabetes or 
heart failure about similar 
health problems in their 
family histories, while gy-
naecologists should be able 
to discuss issues involved 
in prenatal diagnostics dur-
ing consults. Therefore, our 
project has resulted in the 
website ‘GPs and Genetics’ 
where answers to such ques-
tions can be easily found.” 
Isa Houwink, Martina Cor-
nel: Genomics training for 
primary health care workers
Anthology of project vignettes  
Health5
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“We are in the midst of a 
rupture that will dramati-
cally change the way our life 
is organized and will very 
probably involve a break 
with the epoch of sedentari-
zation to which agriculture 
belongs. What is most 
troubling about a strongly 
IP-based, privatized and 
corporate-led agriculture is 
that it tends to destroy the 
dimension of care and re-
sponsibility that is essential 
to agriculture as a culture. 
Agriculture first of all is a 
system of care. From its very 
beginning, agriculture is 
a taking care of the living, 
cultivating life.” 
Pieter Lemmens, Bart 
Gremmen: Towards a par-
ticipatory, commons-based 
innovation in the agrotech 
industry
“It has been argued that 
eco-genomics may open up 
new forms of interaction 
with nature, holistic rather 
than reductionist, based on 
biocompatibility and sus-
tainability rather than on 
exploitation, and eco-centric 
rather than anthropocen-
tric. We have found that, 
although eco-genomics 
certainly has this potential, 
this change will not occur 
by itself, but requires active 
commitment on the part of 
scientists and societal stake-
holders who must be willing 
to move beyond a view of 
nature as a resource, wait-
ing to be prospected and 
exploited.” 
Sanne van der Hout, Hub 
Zwart: Epistemic profile and 
societal prospects of eco-
genomics
“The value of Sartre’s 
analysis for present biofuel 
debates is not so much that 
he offers a specific frame-
work for analysing existing 
situations, but rather his 
claim that colonisation is 
never only about economic 
dominance but comes with 
a cultural dimension as well. 
Analyses of debates and 
practices regarding biofuels 
should pay attention to this 
cultural dimension of eco-
nomic power. This is highly 
relevant for biofuels, where 
a ‘patent-rush’ has taken 
place during the last five 
years in patenting of biofuel 
technologies.” 
Menno van der Veen, Pa-
tricia Osseweijer: Food vs. 
Fuel: Neo-colonial tenden-
cies in biofuel debates
“Pharmaceutical companies 
are now funding bio-pros-
pecting expeditions in deep 
sea ecosystems, where DNA 
‘lab on a chip’ technology 
can be used at considerable 
depths. This is part of a 
general movement towards 
marine habitats, looking for 
genes, enzymes, anti-freeze 
proteins and other novel 
bio-components.  A deep 
sea ethic in the spirit of Le-
opold’s land ethic must be 
developed to prevent a new 
tragedy of the commons.”
 Erik Dücker, Christoph 
Lüthy: Bioprospecting in the 
Genomics Era
Anthology of project vignettes  
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“New monitoring tools 
for water and soil quality 
based on ecogenomics are 
safe, healthy and profitable 
and can play a vital role in 
realizing a truly sustain-
able bio-based economy. 
Our research supports the 
development and implemen-
tation of these new tools by 
bringing together scientists, 
developers and end-users 
to co-shape a sustainable 
future.” 
Tjerk Jan Schuitmaker, 
Jacqueline Broerse: 
Dialogue as a tool for so-
cietal valorization of envi-
ronmental and industrial 
biotechnology
“In the debate on the use 
of genomics in agriculture, 
it is impossible to separate 
technical issues and their 
consequences from the 
wider context in which they 
emerge and the value is-
sues at stake. The genomics 
debate is a value-driven 
debate. This means that, in 
discussing specific techno-
logical innovations, the val-
ues associated with concepts 
of nature cannot be left out 
of the picture” 
Paul van Haperen, Bart 
Gremmen: Ethical debates 
on naturalness
“Open source is an alternative innovation strategy in which 
knowledge resources are shared among producers, creating 
forms of social life and collaboration through the production 
of items such as seeds. A characteristic feature of knowledge 
commons is their abundance: their surplus of knowledge that 
cannot be completely integrated into commoditized relations. 
This social wealth invites and opens new collaborations, new 
social relations, thereby strengthening the common source 
itself.” 
Pieter Lemmens, Guido Ruivenkamp: 
Genomics and the production of the commons
Anthology of project vignettes  
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Shaking Science: Hèt event waar 
je in gesprek kunt gaan met de life 
sciences. Alles onder het motto: 
wetenschap ontmoet samenleving, 
samenleving ontmoet wetenschap. 
De hele maand november kun je in heel 
Nederland workshops, filmavonden, 
debatten, lezingen en tentoonstellingen 
bezoeken over wat nieuwe kennis en 
technologie voor jou kan betekenen.  
Activiteiten die inspireren en je stof tot 
nadenken geven. 
Check www.shakingscience.nl voor meer informatie!
30 dagen 
life ScienceS  
& Samenleving  
in geSprek
november 2012 
door heel  
nederland 
ShakingScience.nl
“Bioinformatics and its 
computational tools con-
stitute the infrastructure of 
genomics research.  A num-
ber of value decisions are 
involved in the development 
of such tools. However, once 
ready for use, these values 
tend to blend into the back-
ground. This may lead to 
the ‘naturalisation’ of value-
laden aspects of identity on 
the population level such 
as nationality, ethnicity and 
descent.” 
Jan van Baren, Hub Zwart: 
Bioinformation and identity
“The concept of immunisa-
tion has migrated from viral 
genomics to public discourse 
to such an extent that it 
has become a paradigm for 
addressing societal issues 
and concerns. One of the 
implications is that auto-
immunisation (i.e. the pos-
sibility of disruptive immune 
responses due to overreac-
tion) becomes a serious risk 
for society at large.” 
Inge Mutsaers, Hub Zwart: 
Immunisation and its dis-
contents
“Rather than criticising sci-
ence, or being locked into 
current scientific views of the 
future, science fiction may 
‘think along’ with science, 
probing changing conditions 
of a technoscientific world 
in which new possibilities 
of life are opened up as pro-
cesses of becoming, teeming 
with potential. Thus, sf may 
allow us to explore the po-
tentials of science and tech-
nology in ways unforeseen 
by science itself.” 
Tom Idema, Hub Zwart: 
Genomics Novels as Test-
Beds for Genomics Futures
“Genomics has come to 
play a key role in how we 
see ourselves. In archaeo-
logical excavations in the 
Netherlands, DNA is now 
giving an identity to a place, 
but often, DNA is mobilized 
in to confirm pre-existing 
icons of identity.” 
Masae Kato, Amade 
M’charek: Dutch-ness in 
Genes and Genealogy
Anthology of project vignettes  
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“We see the valorisation 
policy of the Dutch genom-
ics research system as a 
manifestation of a changing 
social contract between sci-
ence and society, focusing 
on economic value creation 
and the stimulation of en-
trepreneurship. A societal 
debate has emerged, how-
ever, in which this one-sided 
focus on economic aspects 
is criticized. We have found 
that in their daily business, 
genomics researchers con-
tinue to search for relevance 
in several directions, far 
beyond the strictly economic 
one.” 
Dirk Stemerding, Stefan 
Kuhlmann: Genomics as a 
new innovation regime
“We identified five require-
ments for stimulating and 
facilitating the active in-
volvement of researchers in 
policy making: Motivation, 
Task coordination, Commu-
nication competence, Rec-
ognition and Credibility. We 
are now developing tools for 
linking our results to gov-
ernance at the institutional 
level.” 
Zuzana van der Werf Kuli-
chova, Patricia Osseweijer: 
Engaging researchers active-
ly in agricultural biotechnol-
ogy policy making
Responsible Innovation Col-
lective (‘Proeffabriek’) is a 
CSG consultancy spin-off for 
responsible innovation. It 
supports knowledge-inten-
sive organisations with inte-
grating social responsibility 
in their work. Strengthening 
the relation between re-
search organizations and the 
users of knowledge (com-
panies, policy makers, the 
media and citizens) is central 
to our work.
Daan Schuurbiers: 
Responsible Innovation 
Collective
“Building on our project 
results, options are now 
explored to launch a consul-
tancy spin-off that aims to 
stimulate socially responsi-
ble innovation management 
within the private Dutch 
Industrial Life Sciences sec-
tor.”
Steven Flipse, Patricia Os-
seweijer: Challenges and 
Hurdles in Genomics-based 
Innovation
Anthology of project vignettes  
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“An important aspect of  
science communication is: 
to empower scientists to 
reflect on their communica-
tion style in a systematic 
way, making it more interac-
tive, for instance by actively 
inviting feedback from their 
audience” 
Karen Mogendorff, 
Bart Gremmen: Defining 
expertise and citizenship in 
plant genomics
“Emotions should be em-
braced in the public engage-
ment process as being cru-
cial in how people connect 
to the transition towards a 
bio-based economy. A more 
affective approach, using 
images and artworks, pro-
vides insight into people’s 
involvement the issue and 
may allow us to enhance 
their engagement. Moreover, 
it allows public audiences to 
create their own perspective 
on the issue, strengthening 
their own level of agency 
and interaction.”
Susanne Sleenhoff, Patricia 
Osseweijer: Values of Emo-
tions for Public Engagement 
with the Bio-based Economy
“When experts mobilize 
their authority about the 
technological feasibility of 
new developments, this may 
discourage public delibera-
tions concerning their moral 
desirability. As a moderator 
of public deliberations, you 
can empirically analyse and 
improve deliberative quality 
by combining observation 
with assessment and inter-
vention. It works!” 
Koen Dortmans, 
Tsjalling Swierstra: 
Doing dialogue and DNA
Anthology of project vignettes  
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“Our study shows how 
animations, graphics and 
visual models can become 
powerful educational tools 
for developing a multi-level 
perspective on life, enabling 
students to bridge biological 
phenomena on molecular 
and cellular levels and to 
grasp cellular complexity in 
life-science education.” 
Marc van Mill, Arend-Jan 
Waarlo: Educating for visual 
literacy in a genomics world
“Genomics can improve 
our understanding of how 
children learn. And although 
neurogenomics cannot be 
brought into the classroom 
directly, interaction between 
neuro-scientists, didactics 
experts and teachers is a 
point of departure.”
Rosanne Edelenbosch, Jac-
queline Broerse: Strategies 
for implementing neurog-
enomics in education
“To engage young people 
in life science education ac-
tivities, the feeling that they 
can actually contribute to a 
better world is an important 
success factor. It makes them 
put more effort in their work 
and keeps them motivated. 
Interaction with real scien-
tists and working in real labs 
demonstrate the possibilities 
of a career in science. By 
enabling scientists to partici-
pate in education with sec-
ondary school students, we 
provide them with tools and 
experiences to communicate 
with new target audiences. 
These activities increase 
awareness among students 
and scientists about the so-
cial relevance and personal 
relevance of life sciences.”
Anne-Lotte Masson, Tanja 
Klop: Assessing and under-
standing the effects of life 
science education activities
“All citizens should have 
basic knowledge concerning 
genomics, so as to under-
stand heredity issues in hos-
pital or to make conscious 
decisions on the food we 
buy in supermarkets. Much 
more so than standard biolo-
gy books, Mobile DNA Labs 
provide high school students 
with this type of knowledge. 
Biology curricula must be 
drastically revised to afford 
pupils a more adequate pic-
ture of life and health in the 
genomics era.” 
Dirk Jan Boerwinkel, Arend 
Jan Waarlo: Towards a strat-
egy for embedding genomics 
literacy in science education
Anthology of project vignettes  
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CSG is committed to further responsible 
research, i.e. forms of inquiry that are credible 
and trustworthy, and open to social challenges, 
opportunities and concerns (engaged 
scholarship). Rather than seeing ‘science’ 
and ‘society’ as two separate entities, science 
is embedded in society as much as society is 
embedded in science. Genomics and other life 
sciences fields cannot be adequately understood 
nor conducted without paying due attention 
to these social dimensions. Our work is carried 
out in close collaboration with others: with life 
science researchers, with peers and colleagues 
at various universities in the Netherlands and 
abroad, but also with societal stakeholders 
(government, media, industry, professionals, 
intermediary organisations and media). 
Interactive research is not a specific method, 
but a basic attitude, an ethos if you like. It 
means seeing scientific and societal stakeholders 
not as ‘consumers’ of our knowledge, but as 
sources of inspiration and information and 
as partners in our work. Sharing preliminary 
analyses and critical assessments with them 
is bound to make our research more relevant, 
robust and precise. Interaction means that we 
see ourselves not as outsiders, but as active 
participants in knowledge production and 
innovation. Proximity to science is of key 
importance. We offer our expertise to life 
science consortia to help them strengthen the 
social robustness and responsiveness of their 
research activities.
This means that our research co-evolves with 
activities that are often listed under headings 
such as communication and valorisation. 
We see such activities, however, as mutual 
learning exercises and as a cyclical process. 
We share our preliminary views with scientists 
and stakeholders, asking them for their 
comments, identifying key parameters such 
as issues, research questions and valorisation 
opportunities together, so that interaction 
becomes part of the research methodology. 
To support this process, a sizable portfolio of 
actions has been developed by the CSG staff 
with tangible results:
1.  Interactive research - Every CSG research 
project has built mutual learning activities 
(workshops, focus groups, mutual learning 
exercises,  science cafés, public lectures, 
mass media publications, etc.) into the 
research design. Lessons were learned, 
shared (during Researchers Days) and 
reported on ‘best practices’, efficiency 
and effectiveness. Extra funding was 
available to cover expenses for additional 
valorisation activities if necessary.
2.  During our CSG Researchers days, 
concepts such as interaction, mutual 
learning and valorisation were discussed, 
statements were invited, case studies were 
presented and group discussions were 
organised which contributed to critical 
reflection on our work, prepared early stage 
researchers for the societal embedding of 
their research results.
3.	 	Via	six	mobile educational DNA labs, 
developed in collaboration with six 
NGI genomics centres and operated in 
close interaction with our website All 
about DNA (below), we learned how 
to successfully embed genomics-related 
items in curricula and raised the level of 
awareness of genomics and its societal 
dimensions among secondary school 
students. Thus, we contributed to prepare 
the ground for the societal and professional 
debate of the future. More than 100.000 
Dutch high school students have visited 
our mobile labs over the years. They were 
confronted with acute questions they 
may encounter later in life, as researcher, 
professional or citizen. The DNA labs, 
From interaction to mutual learning
5
26CSG NEXT 2008-2013
whose prototype was developed by the 
Centre for BioSystems Genomics, were 
awarded	the	NGI	Valorisation	Award	of	
2011.
4.  The website All about DNA (‘Alles 
over DNA’) developed and maintained 
by CSG, not only functioned as the 
online hub for the DNA labs, but also 
as an important source of information 
on genomics and the life sciences and 
their societal dimensions in its own right, 
notably for secondary school students 
and teachers. It offers a wealth of easily 
accessible background information on 
genomics technologies and concepts as 
well as ready-made teaching modules on 
specific themes. The website attracts more 
than 10.000 visitors monthly. 
5.  Since 2009 we have published the CSG 
magazine LEV (10 issues) covering in a 
lively and accessible manner the various 
ways in which CSG research adds to 
policy, professional practice and education.
6.  Through Imagine (a ‘spin-off’ and 
collaboration with the Kluyver Centre) we 
identified key success factors in education 
and communication of genomics and its 
ethical and social dimensions. Moreover, 
we actively involved hundreds of 
secondary school students and teachers in 
technology development for developing 
countries.
7.  In November 2012 we organised a full 
month of mutual learning activities 
(science cafés, lectures, demonstration, 
cinema debates, exhibitions) under the 
title Shaking Science! Representatives 
from virtually all CSG projects took part 
in this wave of events to put our lessons 
into practice.   
8.  We presented results of CSG projects at 
various existing podiums, not only local 
podiums such as debating centres, but also 
highly visible national and international 
podiums such as the Health Council of 
the Netherlands, the Centre for Ethics and 
Health and the Professional and Public 
Policy Committee of the European Society 
of Human Genetics (Dondorp & De Wert 
2010) also with the aim to learn from 
the comments and suggestions by policy 
makers and professionals on national and 
international levels. 
9.  We published a series of CSG reports 
to share research results with broader 
audiences and professionals. 2
10.  We developed and tested a serious game 
on the bio-based economy with teacher 
instructions.
11.  We organised a conference on open 
source alternatives to current IPR regimes 
covering Trademarks, Patents, Plant 
Breeders’ Rights and Database Rights 
(Brussels 2011)
12.  We organised two conferences in the 
Netherlands and one in Brussels (2013) 
on responsible promise management 
(‘promisomics’) in life sciences research, in 
collaboration with four technology centres 
funded by NGI. 
13.  We organised an international 
meeting with the World Intellectual 
Property Organisation (WIPO) and 
the International Centre for Trade and 
Sustainable Development (ICTSD) to 
discuss the strategies for technology transfer 
through (free/marginal cost) licensing to 
developing countries (Geneva, 2013)
14.  We are currently developing tools for RRI 
in industrial R&D settings
15.  For a more detailed account of our 
valorisation results, readers are invited to 
consult our report Science of life: the value 
of societal research, available on the CSG 
website.2  
2.   Available on the CSG website: www.society-lifesciences.nl - Publications
5
27CSG NEXT 2008-2013
Scientific output
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Title Funding Lead CSG
Towards a sustainable bio-
based society: Aligning 
scientific and societal agendas 
for Bio-Innovation
ESF CSG (Zwart)
Osseweijer; 
Korthals
Neuro-enhancement 
Responsible Research and 
Innovation (NERRI)
EU FP7 MML
LSE (Gaskell)
SV (Noronha)
Zwart (WP3) 
Mutual learning 
exercises
PARRISE EU FP7 MML Freudenthal Institute
Knippels (FI, 
van Dam)
KIT EU FP7 MML Karlsruhe KIT Waarlo
Embedding of CSG
The CSG network / research community is 
becoming firmly embedded. Many researchers 
on CSG projects have found new positions 
both inside and outside academia. Six CSG 
researchers for instance have been appointed 
as professors. Moreover, a series of new projects 
have been developed in collaboration for 
which funding has been acquired outside the 
NGI grant. Notably, the CSG network became 
involved in four new European projects:
Designers & Artists 4 
Genomics 2012, Aqua Vita 
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Spin-offs 
Three former CSG researchers have 
decided to valorise their expertise as 
private consultants.
 
Daan Schuurbiers set up De Proeffabriek 
(Responsible Innovation Collective), CSG’s 
first spin-off. The Responsible Innovation 
Collective is a consultancy for responsible 
innovation. It supports knowledge-
intensive organisations to integrate social 
responsibility in their work, strengthening 
the interaction between research 
organisations and ‘users’ of knowledge 
(companies, policy organisations, research 
funders, the media and citizens). The 
Responsible Innovation Collective 
provides advice, organises training 
sessions and other activities and supports 
interaction and engagement projects, 
also on the EU level. For instance, the 
Responsible Innovation Collective is 
involved in the EU support Action 
NanoDiode, fostering Europe-wide 
outreach and dialogue on governance of 
nanotechnology, combining upstream, 
midstream and downstream engagement, 
thus adding to the further development of 
RRI in the nano field. But the company 
also supports projects on responsible data 
management for personalised Diagnostics 
(ReDaPeD) and translational medicine 
(with CTMM). www.proeffabriek.nl
Steven Flipse conducted a CSG research 
project on how to stimulate responsible 
innovation practices in the Dutch Life 
Sciences industry and now works as a 
consultant. He has developed a licensable 
software tool that supports organisations 
in innovation project execution. The tool 
scores project quality based on technical 
performance indicators, but also on 
success factors relating to social, societal 
and financial-economic indicators. 
Combined with coaching activities, 
the tool helps innovators complete 
innovation projects more effectively and 
efficiently, with less financial resources. 
www.stevenflipse.com
Menno van der Veen did a CSG research 
project on the transformation towards 
a bio-based society and started Tertium, 
which organises workshops, debates and 
other activities to bridge the knowledge 
gap between science and society, and 
between wealthy and less affluent regions 
of the globe, notably focusing on the 
public sector. www.tertium.nl
Dr Daan Schuurbiers
Lookwatering 36 • 2614 KA Delft m +31 6 143 652 16 
e daan@proeffabriek.nl w www.proeffabriek.nl
De Proeffabriek
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In the context of CSG, a solid network of 
principal investigators has evolved, in combi-
nation with a community of senior and early 
stage researchers and an international network 
of peers. We have decided to continue and 
strengthen this PI network during the years to 
come. By joining forces, making use of our com-
plimentary expertise and strategic positions, the 
CSG PI network already managed to develop 
and acquire funding from various sources (both 
NL and EU) for a significant portfolio of new 
(post-CSG Next) projects conducted at several 
universities.  We have agreed to continue and 
intensify our collaboration notably in view of 
the recognised valuable contribution of our 
expertise and knowledge in the context of 
Horizon2020.  The EU will provide substantial 
resources (~500.000,- euro) for research and 
other activities under the heading of Respon-
sible Research and Innovation (RRI). We want 
to use the added value of our collaborative PI 
network to exchange strategic information and 
to mutually support one another in generating 
competitive proposals for (both stand alone and 
embedded) RRI research and interaction activi-
ties. 
CSG Network for Society and the  
Life Sciences
On the national level, CSG will continue as a 
research network. 
The objective of the network is threefold:
•	 	The	Network	as	an	expert network. We 
want to strengthen our position as an intel-
lectual partner for the European Commis-
sion and the international peer community 
in further developing the RRI approach 
through (international) meetings, lectures 
and strategic activities, notably (but not  
exclusively) in the context of Horizon2020.
•	 	The	Network	as	a	‘proposal machine’. 
Building on our expertise and international 
peer networks, we will join forces to create 
optimal conditions for developing com-
petitive proposals in the context of Hor-
zion2020. In response to specific calls, teams 
will be set up, with PIs ‘taking turns’ in 
acting as coordinator for work-packages or 
proposals (MML and otherwise), but build-
ing on support from others.   
•	 	The	Network	as	a	research community. 
We will organise research days for mutual 
learning and exchange, where early stage 
researchers can learn the trade of RRI (ca-
pacity building) through lectures, interac-
tive sessions and discussions, while making 
the output of new projects, as well as the 
legacy from previous CSG projects, avail-
able through the Network website (open 
access repository). 
 
Prof. Hub Zwart will continue to lead and 
represent CSG in the period 2014-2015. The 
research focuses on a number of key (post-
genomics) themes such as: bio-based society, 
sustainable bio-innovation, personalised health 
and human enhancement. The new network 
meets for the first time in December 2013.
LISTEN network 
A similar structure has been set up at the inter-
national level, namely LISTEN (Life Sciences, 
Innovation and Society Network). Our goal is 
to strengthen en develop this international net-
work in parallel, predominantly at a European 
level (in view of contributions in the context of 
Horizon2020), but also on a global scale. So far, 
this has led to four EU FP7 projects (on neuro-
enhancement, synthetic biology and two on  
science education) and an ESF Conference 
Series on sustainable bio-innovation, but also 
in the launch of an open access journal with 
Springer, the Life Sciences, Society and Policy 
journal,4 edited by Ruth Chadwick and Hub 
Zwart.    
Our agenda for the years to come: 
National and international networks for 
Life Sciences ELSA/RRI
4.   www.lsspjournal.com
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